COVID-19 Latest News: IMPORTANT! Second and third phase trail for Covaxin for 2-18 years old APPROVED, check update on COVID-19 Singapore variant

0 59

 Providing some amount of relief to the people, the Drugs Controller General of India (DCGI) has approved Covaxin for the second and the third phase of clinical trials for children between the age of 2 and 18 years. 

Leave A Reply

Your email address will not be published.